Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Machine learning for novel phenotyping in schizophrenia.

Schizophrenia research - 1 Nov 2025

Bareis Natalie, Wang Yuanjia, Olfson Mark, Gerhard Tobias, Dixon Lisa, Stroup T Scott

Abstract excerpt

PURPOSE: Heterogeneity among people diagnosed with schizophrenia-spectrum disorders (schizophrenia) and high prevalence of co-occurring disorders makes identification of optimal treatments difficult. This study identified behavioral health phenotypes using machine learning with Medicaid claims of adults with schizophrenia. We compared the phenotypes' clinical outcomes and psychotropic medication prescription...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Schizophrenia
Share to United States
Share to Young Adult

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Phenotype

Share to Psychotropic Drugs

Share to Adolescent

Share to Comorbidity

Share to Machine Learning

Source

Open in PubMed Open full text

Identifiers

PMID: 40913935
DOI: 10.1016/j.schres.2025.08.011
PMCID: PMC12619572

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Machine learning for novel phenotyping in schizophrenia.PMID 40913935Read ↗

Identifying phenotypic signatures of neuropsychiatric disorders from electronic medical records.Semantic proximity Read ↗

Identifying modifiable comorbidities of schizophrenia by integrating electronic health records and polygenic riskSemantic proximity Read ↗

PhenoPredict: A disease phenome-wide drug repositioning approach towards schizophrenia drug discovery.Semantic proximity Read ↗

Pathway-Phenotypes of Non-responders and Partial Responders to Treatment With Antipsychotics in Schizophrenia: A Machine Learning StudySemantic proximity Read ↗

Multi-Trait Genetic Insights Into Schizophrenia Across Ancestries: Genome-Wide Association Meta-Analyses, Machine Learning, and Drug Repurposing Study.Semantic proximity Read ↗

Clinical deep phenotyping of treatment response in schizophrenia (CDP-STAR): design and methodology of a prospective multimodal observational study.Semantic proximity Read ↗

Subtyping Schizophrenia Using Psychiatric Polygenic ScoresSemantic proximity Read ↗

Pharmacogenomic scores in psychiatry: Systematic review of existing evidenceSemantic proximity Read ↗

Pathway and network embedding methods for prioritizing psychiatric drugsSemantic proximity Read ↗

Medication and pharmacogenomic effects on cross-sectional symptom severity and cognitive ability in schizophreniaSemantic proximity Read ↗

Precision medicine for psychotic disorders: objective assessment, risk prediction, and pharmacogenomicsSemantic proximity Read ↗

Testing Psychosis Phenotypes From Bipolar-Schizophrenia Network for Intermediate Phenotypes for Clinical Application: Biotype Characteristics and Targets.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.